Peraso Inc. (PRSO): Nasdaq/NYSE listing notice — Peraso receives Nasdaq deficiency notice for minimum bid price below $1

Peraso Inc.

Received Nasdaq letter on April 4, 2025, due to closing bid price below $1 for 30 consecutive business days ending April 3.
Company has 180 calendar days (until October 1, 2025) to regain compliance.
To regain compliance, closing bid price must be at least $1 for at least ten consecutive business days.
If non-compliant after initial period, may seek second 180-day compliance period if meeting other listing standards.
Company is evaluating options; delisting not immediate but risk exists.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Peraso Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 4, 2025, Peraso Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock (“Common Stock”) for the 30 consecutive business days ending on April 3, 2025, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until October 1, 2025, in which to regain

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Peraso Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-029053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.